Wu HL, Luo ZY, He ZL, Gong Y, et al. All HER2-negative breast cancer patients need gBRCA testing: cost-effectiveness and clinical benefits. Br J Cancer 2022 Dec 23. doi: 10.1038/s41416-022-02111.
PMID: 36564566